EDESA BIOTECH, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
EDESA BIOTECH, INC. (EDSA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 374 shares for the 9-month period ending 2025-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-13
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-09-30 was -30.87K shares, a 186.61% decline year-over-year.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-06-30 was 35.57K shares.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-03-31 was 0.00 shares.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 4.80K shares, a 86.53% decline from fiscal 2023.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 35.67K shares.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2015 was 8.66K shares, a 5088.62% increase from fiscal 2014.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2014 was 167.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-13 | 374.00 shares 10-Q · filed 2026-08-13 | ||||||
| 2025-03-31 | 374.00 shares 10-Q · filed 2026-05-14 | |||||||
| 2024-09-30 | -30.87K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | 4.70K shares derived: sum of 2 quarters · filed 2025-12-12 | 4.70K shares derived: sum of 3 quarters · filed 2025-12-12 | 4.80K shares 10-K · filed 2025-12-12 | 35.67K shares 10-K · filed 2024-12-13 | |||
| 2024-06-30 | 35.57K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | 35.57K shares derived: sum of 2 quarters · filed 2025-08-08 | 35.67K shares 10-Q · filed 2025-08-08 | 71.31K shares derived: sum of 4 quarters · filed 2025-12-12 | ||||
| 2024-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | 106.00 shares 10-Q · filed 2025-05-14 | 35.75K shares derived: sum of 3 quarters · filed 2025-12-12 | 35.75K shares derived: sum of 4 quarters · filed 2025-12-12 | ||||
| 2023-12-31 | 106.00 shares 10-Q · filed 2025-02-14 | 35.75K shares derived: sum of 2 quarters · filed 2025-12-12 | 35.75K shares derived: sum of 3 quarters · filed 2025-12-12 | 35.75K shares derived: sum of 4 quarters · filed 2025-12-12 | ||||
| 2023-09-30 | 35.64K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | 35.64K shares derived: sum of 2 quarters · filed 2025-12-12 | 35.64K shares derived: sum of 3 quarters · filed 2025-12-12 | 35.67K shares 10-K · filed 2025-12-12 | 38.00 shares 10-K · filed 2024-12-13 | |||
| 2023-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | 0.00 shares derived: sum of 2 quarters · filed 2024-08-09 | 34.00 shares 10-Q · filed 2024-08-09 | 238.00 shares 10-Q · filed 2023-08-09 | ||||
| 2023-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-10 | 34.00 shares 10-Q · filed 2024-05-10 | 238.00 shares 10-Q · filed 2023-05-11 | |||||
| 2022-12-31 | 34.00 shares 10-Q · filed 2024-02-09 | 238.00 shares 10-Q · filed 2023-02-10 | ||||||
| 2022-06-30 | 45.44K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-09 | 45.44K shares derived: sum of 2 quarters · filed 2023-08-09 | 45.65K shares 10-Q · filed 2023-08-09 | |||||
| 2022-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-11 | 214.00 shares 10-Q · filed 2023-05-11 | ||||||
| 2021-12-31 | 214.00 shares 10-Q · filed 2023-02-10 | |||||||
| 2021-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-14 | 238.00 shares 10-Q · filed 2021-05-14 | 238.00 shares derived: sum of 3 quarters · filed 2021-05-14 | 452.00 shares derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2020-12-31 | 238.00 shares 10-Q · filed 2021-02-16 | 238.00 shares derived: sum of 2 quarters · filed 2021-05-14 | 452.00 shares derived: sum of 3 quarters · filed 2021-05-14 | 452.00 shares derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2020-09-30 | 0.00 shares derived: 10-Q 12 month − 10-Q 9 month · filed 2021-05-14 | 214.00 shares derived: sum of 2 quarters · filed 2021-05-14 | 214.00 shares derived: sum of 3 quarters · filed 2021-05-14 | 333.00 shares 10-Q · filed 2021-05-14 | ||||
| 2020-06-30 | 214.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-12 | 214.00 shares derived: sum of 2 quarters · filed 2020-08-12 | 333.00 shares 10-Q · filed 2020-08-12 | 2.54K shares derived: sum of 4 quarters · filed 2020-12-07 | ||||
| 2020-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-15 | 119.00 shares 10-Q · filed 2020-05-15 | 2.33K shares derived: sum of 3 quarters · filed 2020-12-07 | |||||
| 2019-12-31 | 119.00 shares 10-Q · filed 2020-02-13 | 2.33K shares derived: sum of 2 quarters · filed 2020-12-07 | ||||||
| 2019-09-30 | 2.21K shares derived: 10-K 9 month − 10-Q 6 month · filed 2020-12-07 | 3.27K shares 10-K · filed 2020-12-07 | ||||||
| 2019-06-30 | 1.06K shares 10-Q · filed 2019-08-14 | |||||||
| 2019-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-15 | 3.27K shares 10-Q · filed 2020-05-15 | 7.93K shares 10-Q · filed 2019-05-08 | 3.86K shares derived: sum of 3 quarters · filed 2020-05-15 | 3.86K shares derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | 3.27K shares 10-Q · filed 2020-02-13 | 2.20K shares 10-Q · filed 2019-02-05 | 3.86K shares derived: sum of 2 quarters · filed 2020-02-13 | 3.86K shares derived: sum of 3 quarters · filed 2020-02-13 | -5.14K shares derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2018-09-30 | 595.00 shares derived: 10-Q 12 month − 10-Q 9 month · filed 2019-05-08 | 595.00 shares derived: sum of 2 quarters · filed 2019-05-08 | -8.40K shares derived: sum of 3 quarters · filed 2019-05-08 | 2.27K shares 10-Q · filed 2019-05-08 | ||||
| 2018-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08 | -9.00K shares derived: sum of 2 quarters · filed 2018-08-08 | 1.67K shares 10-Q · filed 2018-08-08 | |||||
| 2018-03-31 | -9.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-07 | 1.67K shares 10-Q · filed 2018-05-07 | ||||||
| 2017-12-31 | 10.67K shares 10-Q · filed 2018-02-07 | |||||||
| 2017-09-30 | 4.03K shares 10-Q · filed 2018-08-08 | 28.23K shares 10-Q · filed 2018-02-07 | ||||||
| 2015-09-30 | 8.66K shares 10-K · filed 2015-12-14 | |||||||
| 2014-08-31 | 167.00 shares 10-K · filed 2015-12-14 | 1.67K shares 10-Q · filed 2015-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |